These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of gram-negative infections in patients with renal impairment: new alternatives to aminoglycosides. Whelton A J Clin Pharmacol; 1988 Oct; 28(10):866-78. PubMed ID: 3065360 [TBL] [Abstract][Full Text] [Related]
6. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Brogden RN; Heel RC Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234 [TBL] [Abstract][Full Text] [Related]
7. The newer cephalosporins. Aztreonam and imipenem. Ennis DM; Cobbs CG Infect Dis Clin North Am; 1995 Sep; 9(3):687-713. PubMed ID: 7490439 [TBL] [Abstract][Full Text] [Related]
8. Aztreonam: a review of the first monobactam. Westley-Horton E; Koestner JA Am J Med Sci; 1991 Jul; 302(1):46-9. PubMed ID: 2063887 [TBL] [Abstract][Full Text] [Related]
9. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients. Rabinad E; Bosch-Perez A Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288 [TBL] [Abstract][Full Text] [Related]
10. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients. Rolston KV; Bodey GP; Elting L Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294 [TBL] [Abstract][Full Text] [Related]
11. Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli. DeMaria A; Treadwell TL; Saunders CA; Porat R; McCabe WR Antimicrob Agents Chemother; 1989 Aug; 33(8):1137-43. PubMed ID: 2679368 [TBL] [Abstract][Full Text] [Related]
12. Surgery-related infections: a challenge for the physician. Introduction. Nichols RL Surg Gynecol Obstet; 1990; 171 Suppl():9-10. PubMed ID: 2244296 [No Abstract] [Full Text] [Related]
13. Gram-negative bacillary pneumonia in the nosocomial setting. Role of aztreonam therapy. Cook JL Am J Med; 1990 Mar; 88(3C):34S-37S; discussion 38S-42S. PubMed ID: 2316557 [TBL] [Abstract][Full Text] [Related]
14. Antibiotics in the second half of the 1980s. Areas of future development and the effect of new agents on aminoglycoside use. Neu HC Am J Med; 1986 Jun; 80(6B):195-203. PubMed ID: 3460336 [TBL] [Abstract][Full Text] [Related]
15. Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group. Marco V; Gobernado M; Santos M; Rabinad E Chemotherapy; 1989; 35 Suppl 1():81-8. PubMed ID: 2659295 [TBL] [Abstract][Full Text] [Related]
16. UTIs and two new antibiotics in the elderly. Jones SR; Kimbrough R Geriatrics; 1988 Jul; 43(7):49-52, 55-8. PubMed ID: 3290058 [TBL] [Abstract][Full Text] [Related]
17. A review of the pharmacokinetics and pharmacodynamics of aztreonam. Ramsey C; MacGowan AP J Antimicrob Chemother; 2016 Oct; 71(10):2704-12. PubMed ID: 27334663 [TBL] [Abstract][Full Text] [Related]
18. New trends in paediatric antibiotic therapy. Principi N Drugs Exp Clin Res; 1987; 13(9):589-93. PubMed ID: 3428136 [TBL] [Abstract][Full Text] [Related]
19. Role of aztreonam in the treatment of nosocomial pneumonia in the critically ill surgical patient. Boucher BA Am J Surg; 2000 Feb; 179(2A Suppl):45S-50S. PubMed ID: 10802265 [TBL] [Abstract][Full Text] [Related]
20. Aztreonam, a new monobactam antimicrobial. Guay DR; Koskoletos C Clin Pharm; 1985; 4(5):516-26. PubMed ID: 3902330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]